Intalight Saiwei Secures Over RMB 100 Million in Series D Funding and Files IPO Prospectus

Apr 17, 2024 17:30 CST Updated 17:31

Intalight

High-end Ophthalmic Equipment Developer

Instrument Family

Pioneer in Medical Device Media Reports

Share Professional Medical Device Knowledge

Source: PharmaCube Invest

Recently, following the over 300 million yuan C-round financing in 2023 and a tens of millions yuan strategic investment from Huaxia Eye Hospital, Intalight—Intalight (Henan) Technology Co., Ltd. (hereinafter referred to as "Intalight" or "Intalight"), a global high-end optical ophthalmic diagnosis and treatment equipment brand, has received additional capital support. It recently completed a D-round financing of over 100 million yuan led by Haitong Kaiyuan. The funds will mainly be used to increase R&D investment, expand product lines, and accelerate the layout of overseas markets.

With a world-class R&D team possessing over 20 years of Silicon Valley engineering experience, Intalight has built world-leading, integrated software and hardware technology and product competitiveness. Within a year, Intalight completed multiple rounds of financing, with a total amount exceeding 400 million yuan. Investors include top-tier financial institutions in China such as Guoshou Equity, Qianhai Ark, CD Capital, Shenzhen Capital Group, CICC Huirong, and Lingang Blue Bay, as well as two major ophthalmology industry investors, Aier Healthcare and Huaxia Eye. This investment by Haitong Kaiyuan will inject new momentum into Intalight's development!

END

Advancing the "China Innovation" Strategy, Siemens Healthineers Creates a "New" Realm

Jingjian Yuan Integrated Artificial Large Vessel Completes First Enrollment

Chinese-Made Endoscope Breakthrough, Debuts at CMEF

Developing New Quality Productivity, Neusoft Medical Displays Full Line of High-End Products at CMEF

Leap into the Age of Intelligence! Mindray Launches Multi-Matrix New Product Solutions at CMEF

Accelerating the Transformation of Localization Strategy Achievements, Sony Showcases Precision Imaging Solutions at CMEF

China-Made Single-Port Surgical Robot Leads Innovation, Supporting High-Quality Hospital Development

Gathering Momentum for the Long Term: Multiple Medical Device Companies Strategically Partner with JD Health to Achieve a 200% Growth Target in Three Years

Oupuman Di Appears at the 89th CMEF: Focusing on Clinical Needs, Accelerating Product Power Upgrade

Hankshine Brain Science Group Fully Acquires Italian EB Neuro, a European Centennial Neuroelectrophysiology Company

BusinessBusiness cooperation email: qxzj@landianyiliao.com